Beacon Investment Advisory Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
HWAM
MAM
FSA
RPCONE
JWS
VCM
Beacon Investment Advisory Services's SUPN Position: Q3 2026 in Review
Beacon Investment Advisory Services opened a new position in Supernus Pharmaceuticals (SUPN) in Q3 2026: 5 shares worth $216. The stake represents ﹤0.01% of the portfolio and ranks #776 among its holdings.
21 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.
- Beacon Investment Advisory Services held 5 shares of Supernus Pharmaceuticals worth $216 as of Q3 2026.
- Supernus Pharmaceuticals was a new Beacon Investment Advisory Services position in Q3 2026.
- Supernus Pharmaceuticals made up ﹤0.01% of Beacon Investment Advisory Services's portfolio in Q3 2026, its #776 holding.
- 21 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.